CTI BioPharma Corp.
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has CTI BioPharma Corp.'s balance sheet done over the years? Its assets were worth $125,925,000 last year, which is more than in the previous period. 114% of CTI BioPharma Corp.’s total assets is currently financed by debt. Its liabilities reached the amount of $143,502,000, which means an increase by 109% compared compared to last year.
Debt to Assets
| 2013 | 93723000 | 50.96M | 54.38% |
|---|---|---|---|
| 2014 | 92287000 | 53.80M | 58.31% |
| 2015 | 144332000 | 96.91M | 67.15% |
| 2016 | 63843000 | 56.08M | 87.85% |
| 2017 | 54886000 | 38.79M | 70.68% |
| 2018 | 89832000 | 36.89M | 41.07% |
| 2019 | 46280000 | 28.35M | 61.26% |
| 2020 | 58241000 | 18.21M | 31.27% |
| 2021 | 72434000 | 68.66M | 94.8% |
| 2022 | 125925000 | 143.50M | 113.96% |
CTIC Balance Sheet (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 30.42M | 65.44M | 40.39M | 31.14M | 36.43M | 27.21M | 44.00M | 128.18M | 70.93M | 71.63M |
Short term investments | 49.51M | 0 | 12.05M | 2.52M | 30.59M | 0 | 0 | 0 | 0 | 0 |
Net receivables | 15.38M | 0 | 0 | 0 | 13.67M | 4K | 8.15M | 282K | 2.01M | 235K |
Inventory | 733K | 0 | 0 | 0 | 0 | 550K | 1.52M | 2.84M | 4.18M | 5.07M |
Other current assets | 3.33M | 2.93M | 1.87M | 1.91M | 1.77M | 19.15M | 2.14M | 3.66M | 3.37M | 3.56M |
Total current assets | 99.39M | 68.37M | 54.32M | 35.58M | 82.49M | 46.92M | 55.82M | 134.97M | 80.50M | 80.51M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 2.07M | 3.28M | 2.86M | 4.61M | 1.79M | 2.36M | 3.02M | 3.71M | 4.64M | 5.47M |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 23.22M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current assets | 1.22M | 770K | 1.04M | 6.08M | 5.54M | 5.59M | 4.99M | 5.63M | 7.13M | 7.73M |
Total non-current assets | 26.52M | 4.05M | 3.91M | 10.7M | 7.34M | 7.96M | 8.01M | 9.35M | 11.78M | 13.20M |
Total assets | 125.92M | 72.43M | 58.24M | 46.28M | 89.83M | 54.88M | 63.84M | 144.33M | 92.28M | 93.72M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 13.72M | 7.19M | 0 | 0 | 912K | 103K | 578K | 826K | 1.01M |
Short term debt | 48.72M | 48.54M | 4.45M | 4.81M | 4.81M | 444K | 7.94M | 37.37M | 9.01M | 3.15M |
Total current liabilities | 81.13M | 66.65M | 17.03M | 18.48M | 23.05M | 19.25M | 40.64M | 72.40M | 36.34M | 20.06M |
| Non-current liabilities: | ||||||||||
Long term debt | 1.23M | 2.01M | 800K | 7.44M | 9.26M | 13.57M | 11.31M | 19.25M | 8.36M | 10.15M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 61.13M | 0 | 374K | 2.41M | 4.57M | 5.46M | 3.61M | 4.14M | 7.32M | 19.11M |
Total non-current liabilities | 62.36M | 2.01M | 1.17M | 9.86M | 13.83M | 19.53M | 15.44M | 24.51M | 17.46M | 30.89M |
Total liabilities | 143.50M | 68.66M | 18.21M | 28.35M | 36.89M | 38.79M | 56.08M | 96.91M | 53.80M | 50.96M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |